Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000679407 | SCV000806309 | benign | not provided | 2019-11-20 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001194092 | SCV001363366 | benign | not specified | 2023-03-30 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001290913 | SCV001479201 | likely benign | Neurofibromatosis, type 1 | 2020-10-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000679407 | SCV001765352 | likely benign | not provided | 2022-03-29 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 30308447, 34426522) |
Sema4, |
RCV002256464 | SCV002530183 | benign | Hereditary cancer-predisposing syndrome | 2021-12-07 | criteria provided, single submitter | curation | |
Genome- |
RCV001290913 | SCV002561267 | benign | Neurofibromatosis, type 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001290913 | SCV002972742 | likely benign | Neurofibromatosis, type 1 | 2022-11-06 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000679407 | SCV004142566 | benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | NF1: BP4, BS1, BS2 |
Center for Genomic Medicine, |
RCV001194092 | SCV005090312 | likely benign | not specified | 2024-07-31 | criteria provided, single submitter | clinical testing |